Cited 12 times in
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2- advanced breast cancer: MONARCH 2 & 3 trials
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.